caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1124299003

NPI 1124299003

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where NPI 1124299003's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 11 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
3548
EAST TEXAS MEDICAL CENTER2633
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT TYLER1628
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
HEATON, STEUART135189
MOTHER FRANCES HOSPITAL REGIONAL HEALTH CARE CENTER80147
Michael Lewis
Otolaryngology · Tyler, TX
6390
GARB, HOWARD5684
Troy Callender
Otolaryngology · Tyler, TX
5673
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
3445
EAST TEXAS MEDICAL CENTER3037
TEXAS SPINE AND JOINT HOSPITAL, LLC1818
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT TYLER1730
BEVERLY, LARA1621
ANDREWS, JOHN1213
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.